Collegium Pharmaceutical Inc (COLL) is now in the Undervalued zone, suggesting that its current forward PE ratio of 6.01 is considered Undervalued compared with the five-year average of 4.62. The fair price of Collegium Pharmaceutical Inc (COLL) is between 154.82 to 166.06 according to relative valuation method. Compared to the current price of 41.60 USD , Collegium Pharmaceutical Inc By Undervalued By 73.13%.

Relative Value

Fair Zone

154.82-166.06

Current Price：41.60

73.13%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Collegium Pharmaceutical Inc (COLL) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Collegium Pharmaceutical Inc (COLL) has a current Price-to-Book (P/B) ratio of 5.24. Compared to its 3-year average P/B ratio of 4.67, the current P/B ratio is approximately 12.13% higher. Relative to its 5-year average P/B ratio of 4.17, the current P/B ratio is about 25.64% higher. Collegium Pharmaceutical Inc (COLL) has a Forward Free Cash Flow (FCF) yield of approximately 20.10%. Compared to its 3-year average FCF yield of 23.75%, the current FCF yield is approximately -15.38% lower. Relative to its 5-year average FCF yield of 19.25%, the current FCF yield is about 4.44% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for COLL competitors is 447.86, providing a benchmark for relative valuation. Collegium Pharmaceutical Inc Corp (COLL.O) exhibits a P/S ratio of 1.80, which is -99.6% above the industry average. Given its robust revenue growth of 12.92%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of COLL increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of COLL in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is COLL currently overvalued or undervalued?

Collegium Pharmaceutical Inc (COLL) is now in the Undervalued zone, suggesting that its current forward PE ratio of 6.01 is considered Undervalued compared with the five-year average of 4.62. The fair price of Collegium Pharmaceutical Inc (COLL) is between 154.82 to 166.06 according to relative valuation method. Compared to the current price of 41.60 USD, Collegium Pharmaceutical Inc is Undervalued By 73.13%.

What is Collegium Pharmaceutical Inc (COLL) fair value?

COLL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Collegium Pharmaceutical Inc (COLL) is between 154.82 to 166.06 according to relative valuation method.

How does COLL's valuation metrics compare to the industry average?

The average P/S ratio for COLL's competitors is 447.86, providing a benchmark for relative valuation. Collegium Pharmaceutical Inc Corp (COLL) exhibits a P/S ratio of 1.80, which is -99.60% above the industry average. Given its robust revenue growth of 12.92%, this premium appears unsustainable.

What is the current P/B ratio for Collegium Pharmaceutical Inc (COLL) as of Mar 03 2026?

As of Mar 03 2026, Collegium Pharmaceutical Inc (COLL) has a P/B ratio of 5.24. This indicates that the market values COLL at 5.24 times its book value.

What is the current FCF Yield for Collegium Pharmaceutical Inc (COLL) as of Mar 03 2026?

As of Mar 03 2026, Collegium Pharmaceutical Inc (COLL) has a FCF Yield of 20.10%. This means that for every dollar of Collegium Pharmaceutical Inc's market capitalization, the company generates 20.10 cents in free cash flow.

What is the current Forward P/E ratio for Collegium Pharmaceutical Inc (COLL) as of Mar 03 2026?

As of Mar 03 2026, Collegium Pharmaceutical Inc (COLL) has a Forward P/E ratio of 6.01. This means the market is willing to pay $6.01 for every dollar of Collegium Pharmaceutical Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Collegium Pharmaceutical Inc (COLL) as of Mar 03 2026?

As of Mar 03 2026, Collegium Pharmaceutical Inc (COLL) has a Forward P/S ratio of 1.80. This means the market is valuing COLL at $1.80 for every dollar of expected revenue over the next 12 months.

COLL Valuation